{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:02:13Z","timestamp":1784869333533,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Endothelial dysfunction is an early and pivotal event in the development of cardiovascular disease and a key mechanism linked to atherosclerotic plaque formation. Endocan and endoglin are emerging cardiometabolic markers and novel endothelial mediators that promote vascular smooth muscle cell proliferation and migration, contributing to intima-media thickening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to assess endocan and soluble endoglin levels in young adults in the United Arab Emirates (UAE) and the associations among hyperglycemia, dyslipidemia, and endothelial dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      In this cross-sectional case-control study at UAE University, 182 young adults aged 18\u201322 years were classified as normal body weight (BW) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200961) or excess BW (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009121) based on their body mass index. Anthropometry, systolic and diastolic blood pressures (SBP and DBP), inflammatory markers, the lipid profile, HbA1c, and plasma endocan and endoglin were measured. Multivariable linear regression analysis was performed to determine the associations between endoglin and log-transformed endocan and BW status and cardiometabolic variables, adjusting for age, sex, and family history of type 2 diabetes mellitus and hypertension.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 182 participants, 88 (48%) were women, 121 (67%) had excess BW, and the mean (standard deviation) age was 19.96 years (1.79). Compared with the normal body weight group, the excess body weight group had significantly higher SBP, DBP, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      , interleukin-6, apolipoprotein B (Apo-B), and log-transformed endocan (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.041), along with significantly lower high-density lipoprotein-cholesterol (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021) and apolipoprotein A (Apo-A) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.041) levels. In the adjusted models, endoglin was positively associated with excess BW, DBP, TC, and LDL-C, whereas log-transformed endocan was positively associated with excess BW, SBP, DBP, TC, LDL-C, Apo-B, and hs-CRP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among these young adults, elevated endocan and endoglin levels correlated with excess body weight and adverse metabolic profiles. Prospective studies are needed to determine whether these biomarkers predict future cardiometabolic or vascular outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1836882","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:24:53Z","timestamp":1784867093000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical relevance of circulating endocan and endoglin in excess body weight-associated endothelial dysfunction"],"prefix":"10.3389","volume":"13","author":[{"given":"Charu","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubaker","family":"Suliman","sequence":"additional","affiliation":[{"name":"Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Mohammed","family":"Aldhaheri","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Mohammed","family":"Alnuaimi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled Mohamed","family":"Alderei","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sania Mazin","family":"AlHamad","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed Yasin","family":"Pathan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhadi H.","family":"Aburawi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/vhrm.s12187331","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi","year":"2005","journal-title":"Vasc Health Risk Manag"},{"key":"B2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5339\/gcsp.2014.43","article-title":"Endothelial dysfunction and cardiovascular disease","volume":"2014","author":"Widmer","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"key":"B3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/00033197241233054","article-title":"Endocan and endothelial dysfunction in obese women","volume":"76","author":"Madani","year":"2025","journal-title":"Angiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0003319720903586","article-title":"Novel biomarkers for evaluation of endothelial dysfunction","volume":"71","author":"Leite","year":"2020","journal-title":"Angiology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"798699","DOI":"10.3389\/fcvm.2021.798699","article-title":"Endocan: a key player of cardiovascular disease","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1438367","DOI":"10.3389\/fnagi.2024.1438367","article-title":"Endocan, a novel glycoprotein with multiple biological activities, may play important roles in neurological diseases","volume":"16","author":"Liu","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/hco.0000000000000867","article-title":"Endocan: a new marker of endothelial function","volume":"36","author":"Balta","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/0003319721995664","article-title":"Increased carotid intima-media thickness and endothelial cell-specific molecule-1 (endocan) levels in obese children","volume":"72","author":"Nalbanto\u011flu","year":"2021","journal-title":"Angiology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/00365513.2017.1292363","article-title":"P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease","volume":"77","author":"Ustyol","year":"2017","journal-title":"Scand J Clin Lab Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1242\/jcs.117275","article-title":"Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-\u03b2 signaling pathways","volume":"126","author":"Park","year":"2013","journal-title":"J Cell Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.119.13348","article-title":"Soluble endoglin as a marker for preeclampsia, its severity, and the occurrence of adverse outcomes","volume":"74","author":"Lea\u00f1os-Miranda","year":"2019","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5114\/aoms.2018.79488","article-title":"Evaluation of endocan and endoglin levels in chronic kidney disease due to diabetes mellitus","volume":"15","author":"Ekiz-Bilir","year":"2019","journal-title":"Arch Med Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1741-7015-8-86","article-title":"Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients","volume":"8","author":"Bl\u00e1zquez-Medela","year":"2010","journal-title":"BMC Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0234244","DOI":"10.1371\/journal.pone.0234244","article-title":"Obesity and its associated risk factors among school-aged children in Sharjah, UAE","volume":"15","author":"Abduelkarem","year":"2020","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1111\/dom.16389","article-title":"Prevalence of overweight and obesity in adults from the middle east: a large-scale population-based study","volume":"27","author":"Abdelgadir","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"B18","year":"2024"},{"key":"B19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/03014460400027425","article-title":"Childhood obesity in United Arab Emirates schoolchildren: a national study","volume":"32","author":"Al-Haddad","year":"2005","journal-title":"Ann Hum Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e038667","DOI":"10.1136\/bmjopen-2020-038667","article-title":"Prevalence and determinants of overweight\/obesity among school-aged adolescents in the United Arab Emirates: a cross-sectional study of private and public schools","volume":"10","author":"Baniissa","year":"2020","journal-title":"BMJ Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.sbspro.2016.05.231","article-title":"Reviewing youth facility requirements for low-cost housing in Malaysia","volume":"222","author":"Omar","year":"2016","journal-title":"Procedia Soc Behav Sci"},{"key":"B22","year":""},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0319648","DOI":"10.1371\/journal.pone.0319648","article-title":"Association of family history of cardiovascular disease with the prevalence of cardiometabolic risk factors in young adults in the United Arab Emirates: the UAE healthy future study","volume":"20","author":"Mezhal","year":"2025","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.4103\/jfmpc.jfmpc_1675_23","article-title":"Determination of sample size for various study designs in medical research: a practical primer","volume":"13","author":"Bhardwaj","year":"2024","journal-title":"J Family Med Prim Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21608\/ejaps.2014.185935","article-title":"Emara: biochemical significance of soluble endoglin as a possible marker predicting cardiovascular diseases in obese and obese type 2 diabetic patients","volume":"52","author":"Azza","year":"2014","journal-title":"Egyptian J Pure Appl Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2147\/dmso.s458233","article-title":"Association of biomarkers for dyslipidemia, inflammation, and oxidative stress with endothelial dysfunction in obese youths: a case-control study","volume":"17","author":"Sharma","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0159808","DOI":"10.1371\/journal.pone.0159808","article-title":"Subclinical inflammation and endothelial dysfunction in young patients with diabetes: a study from United Arab Emirates","volume":"11","author":"Aburawi","year":"2016","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0210316","DOI":"10.1371\/journal.pone.0210316","article-title":"Dyslipidemia, subclinical inflammation, hepatic cholestasis and endothelial dysfunction in schoolchildren with excess fat: a study from the United Arab Emirates","volume":"14","author":"Aburawi","year":"2019","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5937\/jomb0-25170","article-title":"Serum endocan levels in relation to traditional and non-traditional anthropometric indices in adult population","volume":"40","author":"Klisi\u0107","year":"2021","journal-title":"J Med Biochem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/circresaha.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/biomedicines10071745","article-title":"Obesity and endothelial function","volume":"10","author":"Kajikawa","year":"2022","journal-title":"Biomedicines"},{"key":"B32","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2015.09.030","article-title":"Endocan: a novel inflammatory indicator in cardiovascular disease?","volume":"243","author":"Balta","year":"2015","journal-title":"Atherosclerosis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fmed.2019.00010","article-title":"Endoglin as an adhesion molecule in mature and progenitor endothelial cells: a function beyond TGF-\u03b2","volume":"6","author":"Rossi","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1038\/sj.emboj.7600386","article-title":"Endoglin promotes endothelial cell proliferation and TGF-beta\/ALK1 signal transduction","volume":"23","author":"Lebrin","year":"2004","journal-title":"EMBO J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1836882\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:24:53Z","timestamp":1784867093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1836882\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":34,"alternative-id":["10.3389\/fcvm.2026.1836882"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1836882","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"1836882"}}